Skip to main content

What is LEUKOTAC®?

What is LEUKOTAC®?

LEUKOTAC® (inolimomab) is an immunotherapy monoclonal antibody that targets the interleukin-2 receptor (IL-2), a chemical molecule named cytokine that contributes to the development and proliferation of some white blood cells including T-cells responsible for aGvHD. By linking specifically to the α chain of the receptor (CD25), LEUKOTAC® prevents IL-2 from binding on the surface of the donor’s over-active T-cells which blocks their multiplication.

The efficacy of LEUKOTAC® in steroid-resistant aGvHD lies mainly in its specificity and its preferential affinity to the CD25 receptor found on the surface of T-lymphocytes.

Mode of action of LEUKOTAC®

STAY IN TOUCH WITH OUR LATEST NEWS

Subcribe to our newsletter